回盛生物（300871）7月29日主力资金净流出2760.22万元

Group 1 - The core viewpoint of the news is that Hubei Kewen Biological Technology Co., Ltd. (回盛生物) has shown significant financial growth in its latest quarterly report, with a total revenue of 399 million yuan, representing a year-on-year increase of 92.96% [1] - The company's net profit attributable to shareholders reached 44.5 million yuan, a remarkable year-on-year growth of 371.23% [1] - The company has a current ratio of 1.420 and a quick ratio of 1.162, indicating a strong liquidity position, while its debt-to-asset ratio stands at 47.97% [1] Group 2 - Hubei Kewen Biological has made investments in 13 companies and participated in 50 bidding projects, showcasing its active engagement in the market [2] - The company holds 115 trademark registrations and 63 patents, reflecting its commitment to intellectual property and innovation [2] - Additionally, the company possesses 47 administrative licenses, indicating its compliance and operational capabilities within the industry [2]